Neuropathic pain occurs when nerves are damaged or irritated, often leading to persistent burning, tingling, or heightened sensitivity to touch. In this study, researchers investigated whether cannabigerol (CBG)—a non-intoxicating cannabinoid found in Cannabis sativa—could reduce pain responses in experimental models of both acute and chronic neuropathic pain. Using rodent models, scientists evaluated behavioral pain responses […]
Tag: CBG
Cannabigerol (CBG) May Support Inflammatory Balance in Arthritis-Related Pain (pub. Oct 2025)
Inflammatory joint conditions like rheumatoid arthritis involve immune system over‑activation that leads to pain, swelling, and joint damage. In this study, researchers used a collagen‑induced arthritis model in rats—a widely accepted laboratory model that mimics key aspects of human inflammatory arthritis—to explore how cannabigerol (CBG) might influence inflammation and related joint symptoms. The goal was […]
Cannabigerol (CBG) Shows Neuroprotective Effects After Ischemic Brain Injury in Animal Study (pub. Aug 2025)
Stroke and other forms of cerebral ischemia occur when blood flow to the brain is temporarily reduced, depriving neurons of oxygen and nutrients and often leading to memory loss, inflammation, and long-term brain damage. In this study, researchers investigated whether cannabigerol (CBG)—a non-intoxicating cannabinoid found in hemp—could help protect the brain following transient global cerebral […]